The Amniox comprehensive family of umbilical cord and amniotic membrane products harnesses the unique power of human birth tissue to help expedite regenerative healing across a wide range of specialties as the adjunct for acute and chronic wound applications by helping to:
• Facilitate wound healing
• Manage discomfort
• Manage adhesions
• Expedite functional recovery while reducing the cost of care 1-4
Our pioneering scientists have focused on understanding the properties of human birth tissue—ultimately identifying HC-HA/PTX3 as a key orchestrator in healing in the human fetal environment.5-9
This complex may orchestrate anti-inflammatory, anti-scarring and growth-promoting biological effects that may expedite functional recovery as demonstrated on the ocular space.5,10
Our CRYOTEK® cryopreservation process has been shown to preserve the structural integrity of the HC-HA/PTX3 complex significantly better than heat dehydration—delivering the benefit of the natural tissue to the wound.11,12
Industry experts recognize the increasing burden of non-healing wound infections.
14.5% of Medicare beneficiaries in 2014 (8.2 million patients) were diagnosed with at least one type of wound or wound-related infection. Listed by prevalence:
Estimated conservatively, their annual cost is $28 billion. This cost could range from $31.7 billion to $96.8 billion including wounds as a secondary diagnosis.13
Advanced wound therapy treatments are experiencing a rapid adoption rate as an adjunct to the standard of care. In this webinar, Dr. Alan Block provided a contemporary overview of Amniotic Membrane and Umbilical Cord transplantation and shared challenging cases specific to a variety of lower extremity applications where expedited wound healing and functional recovery are a concern.
You can watch Dr. Block’s webinar in its entirety by signing up for the Physician Portal and accessing archived webinars on-demand by clicking the button below.
1. Marston WA, Lantis II JC, Wu SC, et al. Wound Repair Regen. 2020;1-6.
2. Caputo WJ, Vaquero C, Monterosa A, et al. Wound Repair Regen. 2016;24(5):885-893.
3. Raphael A. J Wound Care. 2016;25(Sup7):S10-17.
4. Bemenderfer TB, Anderson RB, Odum SM, Davis WH. J Foot Ankle Surg. 2019;58(1):97-102.
5. Tseng SC. Invest Ophthalmol Vis Sci. 2016;57(5):ORSFh1-ORSFh8.
6. He H, Li W, Tseng DY, et al. J Biol Chem. 2009;284:20136-46.
7. He H, Zhang S, Tighe S, Son J, Tseng SC. J Biol Chem. 2013;288:25792-803.
8. Zhang S, He H, Day AJ, et al. J Biol Chem. 2012;287:12433-44.
9. Zhang S, Zhu YT, Chen SY, et al. J Biol Chem. 2014;289:13531-42.
10. Tseng SC, Tsubota K. Am J Ophthalmol. 1997 Dec;124(6):825-35.
11. Cooke M, Tan EK, Mandrycky C, He H, O’Connell J, Tseng SC. J Wound Care. 2014;23(10):465-476.
12. Tan EK, Cooke M, Mandrycky C, et al. J Biomaterial T Eng. 2014;4:379-388.
13. Nussbaum SR, Carter MJ, Fife CE, et al. Value Health. 2018 Jan;21(1):27-32.
14. Raphael A, Gonzales J. J Wound Care. 2017;26(Sup10):S38-44.
15. Kirsner RS, Sabolinski ML, Parsons NB, Skornicki M, Marston WA. Wound Repair Regen. 2015 Sep;23(5):737-44.
16. Frykberg RG, Gibbons GW, Walters JL, Wukich DK, Milstein FC. Int Wound J. 2017 Jun;14(3):569-577.